Frequency of TERT promoter mutation and its association with clinicopathologic factors in papillary thyroid carcinoma in Kerala population.

IF 1.3
Dhanya Krishnan, Sandeep Suresh, Nebu A George, K R Anila, S Kannan
{"title":"Frequency of TERT promoter mutation and its association with clinicopathologic factors in papillary thyroid carcinoma in Kerala population.","authors":"Dhanya Krishnan, Sandeep Suresh, Nebu A George, K R Anila, S Kannan","doi":"10.4103/jcrt.jcrt_460_24","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The prevalence of papillary thyroid cancer (PTC) is increasing in India and other high-income countries. A high prevalence of thyroid cancer has been reported in Kerala-a state in southern India. A significant conclusion is that Thiruvananthapuram, the capital of Kerala, ranks first among males and second among women in terms of the incidence of TC in India.</p><p><strong>Objectives: </strong>The objective of this study was to investigate the clinical significance of TERT Promoter mutations in thyroid carcinoma. Specifically, this study aimed to determine the prevalence of TERT promoter mutations in a cohort of patients with thyroid carcinoma and analyze the association between TERT Promoter mutations and clinicopathological characteristics of thyroid carcinoma.</p><p><strong>Materials and methods: </strong>In this study, patients with PTC were enrolled between 2020 and 2021. Mutation analysis of TERT gene promoter was successfully performed in 47 patients using the PCR amplification of TERT promoter region followed by direct sequencing.</p><p><strong>Results: </strong>PTC harboring TERT Promoter mutation was detected in 18 out of 47 patients (38%). The presence of TERT promoter mutations and various clinicopathological characteristics were compared. Statistical analysis reveals that the clinicopathological parameters, such as clinical as well as pathological stage of disease have significant association with the TERT promoter mutations.</p><p><strong>Conclusions: </strong>These findings highlight the potential of TERT promoter mutations as valuable prognostic indicators and suggest their potential utility as therapeutic targets in PTC.</p>","PeriodicalId":94070,"journal":{"name":"Journal of cancer research and therapeutics","volume":"21 1","pages":"80-84"},"PeriodicalIF":1.3000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cancer research and therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jcrt.jcrt_460_24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/2 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The prevalence of papillary thyroid cancer (PTC) is increasing in India and other high-income countries. A high prevalence of thyroid cancer has been reported in Kerala-a state in southern India. A significant conclusion is that Thiruvananthapuram, the capital of Kerala, ranks first among males and second among women in terms of the incidence of TC in India.

Objectives: The objective of this study was to investigate the clinical significance of TERT Promoter mutations in thyroid carcinoma. Specifically, this study aimed to determine the prevalence of TERT promoter mutations in a cohort of patients with thyroid carcinoma and analyze the association between TERT Promoter mutations and clinicopathological characteristics of thyroid carcinoma.

Materials and methods: In this study, patients with PTC were enrolled between 2020 and 2021. Mutation analysis of TERT gene promoter was successfully performed in 47 patients using the PCR amplification of TERT promoter region followed by direct sequencing.

Results: PTC harboring TERT Promoter mutation was detected in 18 out of 47 patients (38%). The presence of TERT promoter mutations and various clinicopathological characteristics were compared. Statistical analysis reveals that the clinicopathological parameters, such as clinical as well as pathological stage of disease have significant association with the TERT promoter mutations.

Conclusions: These findings highlight the potential of TERT promoter mutations as valuable prognostic indicators and suggest their potential utility as therapeutic targets in PTC.

喀拉拉邦人群甲状腺乳头状癌TERT启动子突变频率及其与临床病理因素的关系
背景:在印度和其他高收入国家,甲状腺乳头状癌(PTC)的患病率正在上升。据报道,印度南部喀拉拉邦的甲状腺癌发病率很高。一个重要的结论是,喀拉拉邦首府蒂鲁凡南塔普兰在印度的TC发病率中,在男性中排名第一,在女性中排名第二。目的:探讨甲状腺癌中TERT启动子突变的临床意义。具体而言,本研究旨在确定TERT启动子突变在甲状腺癌患者队列中的患病率,并分析TERT启动子突变与甲状腺癌临床病理特征之间的关系。材料与方法:本研究纳入2020 - 2021年PTC患者。对47例患者进行TERT基因启动子突变分析,采用TERT启动子区PCR扩增,直接测序。结果:47例患者中有18例(38%)检测到携带TERT启动子突变的PTC。比较了TERT启动子突变的存在和各种临床病理特征。统计分析显示,临床病理参数,如疾病的临床和病理分期与TERT启动子突变有显著相关性。结论:这些发现突出了TERT启动子突变作为有价值的预后指标的潜力,并表明它们作为PTC治疗靶点的潜在效用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信